Singapur - anglès - HSA (Health Sciences Authority)

quantum technologies global pte. ltd. - sodium iodide na131i, solution - capsule - sodium iodide na131i, solution 37-5500 mbq

Canadà - anglès - Health Canada

jubilant draximage inc. dba jubilant radiopharma - sodium iodide 131 i - capsule - 7400mbq - sodium iodide 131 i 7400mbq - radioactive agents

Canadà - anglès - Health Canada

jubilant draximage inc. dba jubilant radiopharma - sodium iodide 131 i - solution - 7400mbq - sodium iodide 131 i 7400mbq - radioactive agents

Estats Units - anglès - NLM (National Library of Medicine)

jubilant draximage inc., dba jubilant radiopharma - sodium iodide i-131 (unii: 29vco8achh) (iodide ion i-131 - unii:4gc1foq22u) - iodide ion i-131 1 mci in 1 ml - hicon® is indicated for the treatment of hyperthyroidism and selected cases of thyroid carcinoma. hicon® is contraindicated in: - patients with vomiting and diarrhea [see warnings and precautions (5.7)] . - patients with thyroid malignancies shown to have no iodide uptake, which include the majority of medullary or anaplastic carcinomas. - patients receiving concurrent anti-thyroid therapy [see warnings and precautions (5.1) and drug interactions (7)] . - pregnancy [see warnings and precautions (5.4), use in specific populations (8.1)] . - lactation [see warnings and precautions (5.5), use in specific populations (8.2)] . risk summary hicon® is contraindicated in pregnancy because fetal exposure can lead to neonatal hypothyroidism, which in some cases is severe and irreversible [see warnings and precautions (5.4)] . data from the published literature describe reports of neonatal thyroid abnormalities after fetal exposure; including agenesis of the thyroid and hypothyroidism (see clinical considerations

Grècia - grec - Εθνικός Οργανισμός Φαρμάκων

mallinckrodt medical b.v. holland westerduinweg 3,, p.o.box 3, 1755, petten, - sodium iodide (131 i) - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 37-7400 mbq/caps - sodium iodide (131 i) 37 - 7.400mbq - sodium iodide (131i)

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

ge healthcare limited - sodium iodide (131 i) - capsule - per cent

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

ge healthcare limited - sodium iodide (131 i) - solution for injection - 925 mbq/ml per cent

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

ge healthcare limited - sodium iodide (131 i) - solution for injection - 37 mbq/ml per cent

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

mallinckrodt medical b.v. - sodium iodide (131 i) - capsule - %v/v

Estats Units - anglès - NLM (National Library of Medicine)

humco holding group, inc. - iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4), sodium iodide (unii: f5wr8n145c) (iodide ion - unii:09g4i6v86q), alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - iodine 20 mg in 1 ml - first aid antiseptic first aid antiseptic first aid antiseptic first aid to help prevent infection in minor cuts, scrapes and burns